AC Immune SA (ACIU)
NASDAQ: ACIU
· Real-Time Price · USD
2.09
0.26 (14.21%)
At close: Jun 24, 2025, 3:59 PM
2.20
5.26%
After-hours: Jun 24, 2025, 07:59 PM EDT
14.21% (1D)
| Bid | 2.2 |
| Market Cap | 206.79M |
| Revenue (ttm) | 28.3M |
| Net Income (ttm) | -52.08M |
| EPS (ttm) | -0.63 |
| PE Ratio (ttm) | -3.32 |
| Forward PE | -2.65 |
| Analyst | Buy |
| Ask | 2.2 |
| Volume | 239,764 |
| Avg. Volume (20D) | 144,548 |
| Open | 1.87 |
| Previous Close | 1.83 |
| Day's Range | 1.87 - 2.15 |
| 52-Week Range | 1.43 - 4.37 |
| Beta | 1.58 |
About ACIU
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ACIU
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ACIU stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
AC Immune SA is scheduled to release its earnings on Aug 5, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
7 months ago
+13.42%
AC Immune shares are trading higher after the comp...
Unlock content with
Pro Subscription
9 months ago
+5.81%
AC Immune shares are trading higher after the company announced it will receive the second ReTain-related milestone payment under its agreement with Janssen Pharmaceuticals.
